新闻Pfizer Inc partners with Bindtherapeutics.For instance, Pfizer collaborated with BIND Therapeutics Inc for the development of nanoparticles, called Accurins.
新闻Bindtherapeutics is developing cancer medicine.AstraZeneca is to pay privately held Bind Therapeutics as much as $200 million to develop a cancer medicine using the U.S. biotech company's nanotechnology drug delivery system.
